In group 1, 17 of 23 patients (74%) had no complications. The wound broke down in four patients after removal of sutures. Although these patients had no clinical evidence of infection, wound cultures grew aerobic and anaerobic organisms in three of the four cases. Two other patients required early removal of sutures on the second and ninth postoperative days for wound haematoma and wound infection respectively. There was no evidence of recurrence in either group at six and 12 months follow up.
Comment
Successful day case excision and primary closure of natal cleft sinus is feasible and offers earlier healing than excision and healing by secondary intention. Although primary closure was not always successful, the time to complete healing of unsuccessful cases was not significantly different from that of the secondary healing group (median difference -4; 95% confidence interval -10 to 3).
The failure rate in group 1 is higher than that, reported elsewhere.' Four of the six patients who failed to heal had bacteriological evidence ofwound infection. Kronborg et al have reported that the prophylactic use of clindamycin reduced healing time after primary closure.3 None of our patients received prophylactic antibiotics, and no subcutaneous sutures were used. Use of the outpatient department and district nurse was lower in group The ambulance staff were very enthusiastic and the patients grateful. We believe that the administration of Lucozade and glucagon by ambulance personnel is safe, effective, and financially beneficial. We recommend its extension to other areas. This practice has recently been extended to all of Scotland. We thank Dr K Little, Dr C Robertson, Beechams, Boehringer Mannheim, and Novo-Nordisk. In previous surveys in this hospital we have found malignancy to be the commonest cause of hypercalcaemia. In a retrospective survey hyperparathyroidism accounted for 13% of cases, 22% of cases being of unknown cause. ' In a subsequent, prospective study2 it was suggested that most of the cases of unexplained hypercalcaemia were due to primary hyperparathyroidism. In both surveys hypercalcaemia associated with renal failure was uncommon. We have recently completed a three month review of all hypercalcaemic patients in the same hospital and report here the results.
Patients, methods, and results
In the three months from May to July 1990, 181 hypercalcaemic patients with a corrected calcium concentration ofgreater than 2 * 7 mmol/l were identified from our biochemistry department computer database (correction factor: 0-02 mmol calcium per 1 was added or subtracted/g albumin above or below 40 g/l). the need for treatment in malignant hypercalcaemia is difficult, we suspect that adequate treatment of this condition remains inconsistent. All the cases ofprimary hyperparathyroidism in our survey were routine admissions for surgery. In view of our previous experience it is likely that the unexplained hypercalcaemia was due to primary hyperparathyroidism.
Comment
The most surprising change over the past decade has been the enormous increase in hypercalcaemia associated with chronic renal failure, which occurred in 81 of the 162 patients in our survey. In 32 patients the calcium concentration was greater than 3 0 mmol/l. Fifty three of the 81 patients were receiving calcium or vitamin D supplementation, and in 44 cases the serum calcium concentration returned to normal after reducing or stopping vitamin D or calcium supplementation. Twenty patients had hypercalcaemia which settled without treatment. Only two of the 81 patients subsequently required parathyroidectomy. Twenty one patients in our study developed hypercalcaemia after receiving a renal transplant. Two of these patients became normocalcaemic after stopping calcium supplementation. The others did not require treatment.
In this study there were five cases of transient perioperative hypercalcaemia in liver transplant recipients, probably due to the large intraoperative infusion of calcium during the transplant operation.
The incidence of hypercalcaemia among renal patients seems, at least in part, to be due to calcium carbonate replacing aluminium hydroxide as a phosphate binder, with its concomitant advantages of the avoidance of aluminium toxicity and simultaneous calcium supplementation. The increased incidence of hypercalcaemia with calcium carbonate has been noted in previous studies.4 Although the incidence of symptomatic hypercalcaemia seemed low, we suggest that the treatment of the hypercalcaemia of chronic renal failure with calcium supplements should be monitored more carefully.
We were disappointed that the treatment of the hypercalcaemia of malignancy seemed not to have improved over 10 years despite marked improvement in the efficacy of therapeutic measures available.
